A detailed history of Capstone Investment Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 51,400 shares of VTRS stock, worth $668,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,400
Previous 17,761 189.4%
Holding current value
$668,200
Previous $188,000 217.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $1.01 Million - $1.18 Million
97,518 Added 549.06%
115,279 $1.34 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $99,766 - $119,322
9,927 Added 126.72%
17,761 $188,000
Q1 2024

May 01, 2024

BUY
$11.27 - $13.53 $88,289 - $105,994
7,834 New
7,834 $93,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $76,748 - $90,834
-8,003 Reduced 35.64%
14,455 $142,000
Q2 2023

Aug 10, 2023

SELL
$9.02 - $10.29 $36,585 - $41,736
-4,056 Reduced 15.3%
22,458 $224,000
Q1 2023

May 09, 2023

SELL
$9.2 - $12.26 $377,742 - $503,383
-41,059 Reduced 60.76%
26,514 $255,000
Q4 2022

Feb 10, 2023

SELL
$8.72 - $11.56 $94,821 - $125,703
-10,874 Reduced 13.86%
67,573 $752,000
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $646,031 - $847,916
76,183 Added 3364.97%
78,447 $668,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $211,616 - $260,958
-21,268 Reduced 90.38%
2,264 $24,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $227,121 - $356,540
-23,152 Reduced 49.59%
23,532 $256,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $305,308 - $370,714
25,253 Added 117.83%
46,684 $632,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $209,191 - $238,872
15,788 Added 279.78%
21,431 $290,000
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $76,688 - $104,621
5,643 New
5,643 $79,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.